Tafasitamab,Lenalidomide
Morphosys,Incyte
['lymphoma', 'cml']
nice tables from dr ranjana advani comparing non-t-cell redirecting novel therapies in lymphoma, both approved and non approved #17icml 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem